Jonathan Myers joined Ventac Partners as Partner in August 2014.
Jonathan, who has lived and worked on four continents, has 17+ years experience in VC fundraising as well as phases of pharma/biotech transactions, from initial screening to due diligence to valuation, negotiation and closing. This experience includes practically all deal structures, including in-licensing, out-licensing, joint ventures, and mergers & acquisitions.
Prior to Ventac Partners, Jonathan was Founder and Managing Director of Nine Bridges Capital, a Shanghai based life science financial advisory and business development consulting firm. Jonathan has also worked in various business development and corporate finance roles pharma/biotech industry in the San Francisco Bay Area and in Basel, Switzerland for companies including Pain Therapeutics, Onyx Pharmaceuticals Chiron Corporation and Roche. Jonathan worked on over 50 deals during his time in the Bay Area and accomplishments of note include the completion of a $400M out-licensing deal as well as various in-licensing deals, drug formulation deals, manufacturing deals and option agreements. Jonathan began his pharma/biotech career in a hybrid corporate finance/business development role, building valuation models in support of deal negotiation and running the due diligence process for many deals at Chiron Corporation.
Prior to receiving his MBA from the Rotterdam School of Management, Erasmus University, Jonathan was a chemical process engineer with Nobel Industries (Akzo Nobel), in Sweden, Chile and the United States, having received is BSc degree in chemical engineering from Michigan State University. Jonathan, whose father was an Air Force pilot, spent most of his childhood roaming around the world as an "Air Force Brat".